Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Fingleton

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Acute Medicine|May 26, 2011
Occult bilateral hip fracture secondary to seizure: a case report and literature reviewJames Fingleton
Internal Medicine Journal|December 5, 2025
The Australia New Zealand respiratory audit programme: a new paradigm to improve respiratory careNatasha Smallwood, James Fingleton
Thorax|January 21, 2011
Towards individualised treatment in COPDJames Fingleton, Mark Weatherall, Richard Beasley
Thorax|November 15, 2012
Restriction of LABA use to combination ICS/LABA inhaler therapy in asthmaRichard Beasley, James Fingleton, Mark Weatherall
Current Opinion in Pulmonary Medicine|October 20, 2017
Treatable traits of chronic airways diseaseJames Fingleton, Jo Hardy, Richard Beasley
Thorax|June 14, 2012
Bronchodilator responsiveness: interpret with cautionJames Fingleton, Mark Weatherall, Richard Beasley
The European Respiratory Journal|January 6, 2018
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here?Richard Beasley, Irene Braithwaite, James Fingleton, et al.
Journal of the Royal Society of Medicine|May 24, 2012
Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling studySally Eyers, James Fingleton, Kyle Perrin, et al.
Translational Respiratory Medicine|May 29, 2016
A half doubling dose change in bronchial hyperresponsiveness in a population represents an important differenceMark Weatherall, James Fingleton, Sally Eyers, et al.
Thorax|June 8, 2013
Limited generalisability of UPLIFT findings to clinical practiceSteven Walker, James Fingleton, Mark Weatherall, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Acute Medicine|May 26, 2011
Occult bilateral hip fracture secondary to seizure: a case report and literature reviewJames Fingleton
Internal Medicine Journal|December 5, 2025
The Australia New Zealand respiratory audit programme: a new paradigm to improve respiratory careNatasha Smallwood, James Fingleton
Thorax|January 21, 2011
Towards individualised treatment in COPDJames Fingleton, Mark Weatherall, Richard Beasley
Thorax|November 15, 2012
Restriction of LABA use to combination ICS/LABA inhaler therapy in asthmaRichard Beasley, James Fingleton, Mark Weatherall
Current Opinion in Pulmonary Medicine|October 20, 2017
Treatable traits of chronic airways diseaseJames Fingleton, Jo Hardy, Richard Beasley
Thorax|June 14, 2012
Bronchodilator responsiveness: interpret with cautionJames Fingleton, Mark Weatherall, Richard Beasley
The European Respiratory Journal|January 6, 2018
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here?Richard Beasley, Irene Braithwaite, James Fingleton, et al.
Journal of the Royal Society of Medicine|May 24, 2012
Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling studySally Eyers, James Fingleton, Kyle Perrin, et al.
Translational Respiratory Medicine|May 29, 2016
A half doubling dose change in bronchial hyperresponsiveness in a population represents an important differenceMark Weatherall, James Fingleton, Sally Eyers, et al.
Thorax|June 8, 2013
Limited generalisability of UPLIFT findings to clinical practiceSteven Walker, James Fingleton, Mark Weatherall, et al.
Pageof 7